'CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them' -Wall Street Journal Report
Portfolio Pulse from Benzinga Newsdesk
CVS Health Corp has decided to pull certain cold medicines from its shelves and will stop selling them, according to a Wall Street Journal report. The medicines contain phenylephrine as the only active ingredient.
October 19, 2023 | 7:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CVS Health Corp's decision to stop selling certain cold medicines may impact its revenues in the short term.
CVS's decision to stop selling certain cold medicines could lead to a decrease in sales and potentially impact its revenues in the short term. However, the overall impact will depend on the proportion of revenue these products contribute to the company's total revenue.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100